Comparison of Three D-Dimer Assays for the Diagnosis of DVT: ELISA, Latex and an Immunofiltration Assay (NycoCard D-Dimer)

Summary

Ninety-two consecutive patients referred for suspicion of deep venous thrombosis (DVT) were analyzed for D-dimer using ELISA, latex test, and a new immunofiltration method (NycoCard D-Dimer). Contrast venography verified the diagnosis in 40, and excluded the diagnosis in 52 patients. The sensitivity, negative predictive values, specificity and positive predictive values were, for ELISA 98%, 95%, 38% and 54, for NycoCard D-Dimer 100%, 100%, 42% and 57% and for the latex test 73%, 78%, 75%, and 69%, respectively. Sensitivity and specificity were inversely related with increasing pathological cutoff value. Comparison of test results by concentration category revealed a good agreement between ELISA and NycoCard D-Dimer, but to less extent between latex and the two other tests. It is concluded that NycoCard D-Dimer and D-dimer ELISA are well-suited as exclusion tests for DVT. A plasma sample is tested with NycoCard D-Dimer in less than 2 min. Thus, this test combines advantageous analytical properties comparable to the ELISA-test, with rapidity and simplicity comparable to the latex test.

• References

• 1 Merskey C, Lazezazi P, Johnson AJ. A rapid, simple and sensitive method for measuring fibrinolytic split products in human serum. Thromb Diath Haemorrh 1969; 34: 652-62
• 2 Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ, Wyatt D, Bundesen PG. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-78
• 3 Elms MJ, Bunce IH, Bundesen PG, Rylall DB, Webber AJ, Masci PP, Whitaker AN. Measurement of crosslinked fibrin degradation products-an immunoassay using monoclonal antibodies. Thromb Haemostas 1983; 50: 591-4
• 4 Mirshahi M, Soria J, Soria C, Perrot J-Y, Boucheix C. A latex immunassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody. Thromb Res 1986; 44: 715-28
• 5 Koppert PW, Hoegee-de-Noebel E, Nieuwenhuisen W. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Thromb Haemostas 1988; 59: 310-5
• 6 Plow EF, Hougie C, Edgington TS. Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. J Immunol 1971; 107: 1496-500
• 7 Plow EF, Edgington TS. Discriminating neoantigenic differences between fibrinogen and fibrin derivatives. Proc Nat Acad Sei USA 1973; 70: 1169-73
• 8 Budzynski AZ U, Marder VJ, Parker ME, Shames P, Brizuela BS, Olexa SA. Antigenic markers on fragment DD, a unique plasmic derivative of human crosslinked fibrin. Blood 1979; 54: 794-804
• 9 Francis CW, Marder VJ. A molecular model of plasmic degradation of cross-linked fibrin. Semin Thromb Hemostas 1982; 8: 25-35
• 10 Rowbotham BJ, Carroll P, Whitaker AN, Bunce IH, Cobcroft RG, Elms MJ, Masci PP, Bundesen PG, Rylatt DB, Webber AJ. Measurement of crosslinked fibrin derivatives-use in the diagnosis of venous thrombosis. Thromb Haemostas 1987; 57: 59-61
• 11 Heaton DC, Billings JD, Hickton CM. Assessment of D-dimer assays for the diagnosis of deep vein thrombosis. J Lab Clin Med 1987; 110: 588-91
• 12 Speiser W, Mallek R, Koppensteiner R, Stiimpflen A, Kapiotis S, Minar E, Ehringer H, Lechner K. D-dimer and TAT measurements in patients with deep venous thrombosis: Utility in diagnosis and judgement of anticoagulant treatment effectiveness. Thromb Haemostas 1990; 64: 196-201
• 13 Boneu B, Bes G, Pelzer H, Sie P, Baccalon H. D-dimers, thrombin antithrombin III complexes and prothrombin fragments 1 + 2: Diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemostas 1991; 65: 28-32
• 14 Heijboer H, Ginsberg JS, Biiller HR, Lensing AW A, Colly LP, ten Cate JW. The use of the D-dimer test in combination with non-invasive testing versus serial non-invasivc testing alone for the diagnosis of deep-vein thrombosis. Thromb Haemostas 1992; 67: 510-3
• 15 Carter C, Doyle DL, Dawson N, Fowler S, Devine DV. Investigations into the clinical utility of latex D-dimer in the diagnosis of deep vein thrombosis. Thromb Haemostas 1993; 69: 8-11
• 16 Raimondi P, Bongard O, de Moerloose P, Reber G, Waldvogel F, Bouna-meaux H. D-dimer plasma concentration in various clinical conditions: Implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res 1993; 69: 125-30
• 17 de Boer WA, de Haan MA, Huisman JW, Klaassen CH L. D-dimer latex assay as screening method in suspected deep venous thrombosis of the leg. A clinical study and a review of the literature. Neth J Med 1991; 38: 65-9
• 18 Ibrahim KM A, O’ Neill AI, Parkin DJ. D-dimer (latex) assay in the diagnosis of deep venous thrombosis. Med J Austr 1992; 157: 574-5
• 19 Gogstad GO, Dale S, Brosstad F, Brandsnes Ø, Holtlund J, Mprk E, Gärtner E, Borch SM. A new assay for measurement of D-dimer based on immunofiltration and staining with gold colloids. Clin Chem 1993; 39: 2070-6
• 20 Grau E, Linares M, Estany A, Martin F. Utiity of D-dimer in the diagnosis of deep venous thrombosis in outpatients. Thromb Haemostas 1991; 66: 510
• 21 van Bergen PF M M, Knot EA R, Jonker JJ C, de Boer AC, de Maat MP M. Is quantitative determination of fihrin(ogen) degradation products and thrombin antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?. Thromb Haemostas 1989; 62: 1043-5
• 22 Kroneman H, van Bergen PF M M, Knot EA R, Jonker JJ C, de Maat MP M. Diagnostic value of D-dimer for deep venous thrombosis in outpatients. Haemostas 1991; 21: 286-92
• 23 Eisenberg PR, Jaffe A, Stum DC, Collen, Bovill EG. Validity of immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. Circulation 1990; 82: 1159-68
• 24 Legnani C, Maccaferri M, Palareti G, Coccheri S. New, quantitative enzyme immunoassays for degradation products of fibrin and fibrinogen in plasma: A comparison with other laboratory methods. Fibrinolysis 1990; 4: 189-93
• 25 Boisclair MD, Lane DA, Wilde JT, Ireland H, Preston FE, Ofosu A. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/ fibrin fragment E-antigen. Brit J Haematol 1990; 74: 471-9